G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $595,898 | +2028.2% | 109,339 | +9777.1% | 0.00% | – |
| Q1 2021 | $28,000 | -71.7% | 1,107 | -79.1% | 0.00% | – |
| Q4 2020 | $99,000 | +421.1% | 5,285 | +235.8% | 0.00% | – |
| Q3 2020 | $19,000 | -67.2% | 1,574 | -42.2% | 0.00% | – |
| Q2 2020 | $58,000 | -48.7% | 2,722 | -36.2% | 0.00% | – |
| Q4 2019 | $113,000 | +66.2% | 4,264 | +43.7% | 0.00% | – |
| Q3 2019 | $68,000 | -20.9% | 2,968 | +5.6% | 0.00% | – |
| Q2 2019 | $86,000 | – | 2,811 | +93600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 321 | +122.9% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 144 | -0.7% | 0.00% | – |
| Q2 2018 | $6,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |